Judith Baumeister

1.3k total citations
19 papers, 729 citations indexed

About

Judith Baumeister is a scholar working on Epidemiology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Judith Baumeister has authored 19 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 8 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Immunology. Recurrent topics in Judith Baumeister's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Glycosylation and Glycoproteins Research (3 papers) and Herpesvirus Infections and Treatments (3 papers). Judith Baumeister is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Glycosylation and Glycoproteins Research (3 papers) and Herpesvirus Infections and Treatments (3 papers). Judith Baumeister collaborates with scholars based in Belgium, United States and Netherlands. Judith Baumeister's co-authors include Tobias Wunberg, Helga Ruebsamen‐Schaeff, Thomas Goldner, Peter Lischka, Guy Hewlett, Holger Zimmermann, Hans Ulrichts, Maria Laura Sargentini‐Maier, Alex Hemeryck and Femke Van Bockstaele and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Journal of Virology.

In The Last Decade

Judith Baumeister

19 papers receiving 706 citations

Peers

Countries citing papers authored by Judith Baumeister

Since Specialization

Citations

This map shows the geographic impact of Judith Baumeister's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith Baumeister with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith Baumeister more than expected).

Fields of papers citing papers by Judith Baumeister

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith Baumeister. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith Baumeister. The network helps show where Judith Baumeister may publish in the future.

Co-authorship network of co-authors of Judith Baumeister

This figure shows the co-authorship network connecting the top 25 collaborators of Judith Baumeister. A scholar is included among the top collaborators of Judith Baumeister based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith Baumeister. Judith Baumeister is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Impact of FcRn antagonism on vaccine-induced protective immune responses against viral challenge in COVID-19 and influenza mouse vaccination models 2025 ·Human Vaccines & Immunotherapeutics ·Prajakta Warang, Gagandeep Singh, Mahan Moshir, (unknown), (unknown), Lauren A. Chang, Heidi Wouters, Peter Vanhoenacker, (unknown), (unknown), (unknown), (unknown), Peter Ulrichts, Judith Baumeister, Michael Schotsaert	3
2	Effects of efgartigimod treatment on humoral and cellular immune responses: analysis of T-cell-dependent antibody response in cynomolgus monkeys 2025 ·Journal of Immunotoxicology ·(unknown), Mario Cocco, (unknown), Christopher B. Cooper, Mahan Moshir, Peter Vanhoenacker, (unknown), (unknown), (unknown), Gwenda Pynaert, Peter Ulrichts, Judith Baumeister	4
3	Translational population target binding model for the anti-FcRn fragment antibody efgartigimod 2024 ·Journal of Pharmacokinetics and Pharmacodynamics ·(unknown), (unknown), (unknown), Judith Baumeister, Stefaan Rossenu	2
4	Repeated-Dose Toxicity, Biodistribution, and Shedding Assessments With a ChAd155 Respiratory Syncytial Virus Vaccine Candidate Evaluated in Rabbits and Rats 2022 ·International Journal of Toxicology ·Alan H. Stokes, (unknown), (unknown), Philippe Ancian, Alexandra Rogue, (unknown), (unknown), (unknown), (unknown), Giulietta Maruggi, (unknown), (unknown), Karine Blouin, Guillaume Dubois, (unknown), Judith Baumeister, Ann‐Muriel Steff, Éric Destexhe	1
5	Repeated Dose Toxicity Study and Developmental and Reproductive Toxicology Studies of a Respiratory Syncytial Virus Candidate Vaccine in Rabbits and Rats 2021 ·International Journal of Toxicology ·Alan H. Stokes, (unknown), Daniel E. Fisher, (unknown), (unknown), Niraj Tripathi, Michael A. Ringenberg, (unknown), (unknown), (unknown), (unknown), Ritankar Majumdar, (unknown), (unknown), (unknown), Judith Baumeister	9
6	Chimeric hemagglutinin supra-seasonal universal influenza vaccine candidates administered sequentially by the intramuscular route are locally and systemically well-tolerated in rabbits 2020 ·Regulatory Toxicology and Pharmacology ·Éric Destexhe, (unknown), (unknown), (unknown), (unknown), (unknown), Corey P. Mallett, Judith Baumeister	2
7	The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis 2015 ·Arthritis Research & Therapy ·Maarten Van Roy, Cedric Ververken, Els Beirnaert, (unknown), Joost A. Kolkman, Michel Vierboom, (unknown), Bert ’t Hart, Sofie Poelmans, (unknown), Alex Hemeryck, (unknown), Judith Baumeister, Hans Ulrichts	145
8	Pre-Clinical Intravenous Serum Pharmacokinetics of Albumin Binding and Non-Half-Life Extended Nanobodies® 2015 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Judith Baumeister, Maria Laura Sargentini‐Maier	81
9	ALX-0962, an anti-IgE Nanobody® with a dual mode of action 2013 ·European Respiratory Journal ·Manuela Rinaldi, Tinneke Denayer, Sophie Thiolloy, (unknown), Marie-Ange Buyse, (unknown), (unknown), Peter Meerts, Judith Baumeister, Josefin-Beate Holz	5
10	Benzoxazole and benzothiazole amides as novel pharmacokinetic enhancers of HIV protease inhibitors 2012 ·Bioorganic & Medicinal Chemistry Letters ·Tim H. M. Jonckers, M.C. Rouan, (unknown), Wim Schepens, Sabine Hallenberger, Judith Baumeister, Jennifer C. Sasaki	28
11	Safety of Nanobody® ALX-0651 targeting the G protein coupled receptor CXCR4 2012 ·Toxicology Letters ·(unknown), (unknown), Benedikte Serruys, Veerle Snoeck, Karen Cromie, Judith Baumeister	2
12	Nonclinical safety assessment of the RANK-L targeting Nanobody® ALX-0141 2012 ·Toxicology Letters ·(unknown), Maarten Van Roy, Alex Hemeryck, (unknown), Judith Baumeister	1
13	ALX-0171 toxicity study in RSV-infected cotton rats: Safety and therapeutic potential 2012 ·Toxicology Letters ·G. Hanton, Laurent Detalle, (unknown), Marie‐Paule Bouche, Erik Depla, Judith Baumeister	3
14	Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugs 2011 ·Blood ·Hans Ulrichts, Karen Silence, Anne Schoolmeester, Peter de Jaegere, Stefaan Rossenu, Jan Roodt, Sofie Priem, Marc Lauwereys, Peter Casteels, Femke Van Bockstaele, Katrien Verschueren, Patrick Stanssens, Judith Baumeister, Josefin-Beate Holz	140
15	In Vitro and In Vivo Activities of the Novel Anticytomegalovirus Compound AIC246 2010 ·Antimicrobial Agents and Chemotherapy ·Peter Lischka, Guy Hewlett, Tobias Wunberg, Judith Baumeister, (unknown), Thomas Goldner, Helga Ruebsamen‐Schaeff, Holger Zimmermann	192
16	In Vitro and In Vivo Activities of the Novel Anti-cytomegalovirus Compound AIC246 2010 ·Antiviral Research ·Peter Lischka, Guy Hewlett, Tobias Wunberg, Judith Baumeister, (unknown), Thomas Goldner, Helga Ruebsamen‐Schaeff, Holger Zimmermann	10
17	Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Anti-Vwf Nanobody® ALX-0681 After Single and Multiple Subcutaneous Administrations to Healthy Volunteers. 2009 ·Blood ·(unknown), Pieter W. Kamphuisen, (unknown), (unknown), Izaak den Daas, Femke Van Bockstaele, (unknown), Hans Ulrichts, Judith Baumeister, (unknown), Veerle Compernolle, Josefin-Beate Holz	6
18	Superior Efficacy of Helicase-Primase Inhibitor BAY 57–1293 for Herpes Infection and Latency in the Guinea Pig Model of Human Genital Herpes Disease 2007 ·Antiviral chemistry & chemotherapy ·Judith Baumeister, (unknown), (unknown), Kerstin Henninger, Helga Ruebsamen‐Waigmann, Gerald Kleymann	43
19	Pseudorabies Virus Glycoprotein gK Is a Virion Structural Component Involved in Virus Release but Is Not Required for Entry 1998 ·Journal of Virology ·Barbara G. Klupp, Judith Baumeister, (unknown), Harald Granzow, Thomas C. Mettenleiter	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact